Dysregulation in the Expression of Platelet Surface Receptors in Acute Coronary Syndrome Patients-Emphasis on P2Y12

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Hematology

Background:

• Platelet activation is central to Acute Coronary Syndrome (ACS) pathogenesis.
• While platelet hyperactivity in ACS is known, the molecular basis of altered platelet function requires further investigation.
• Platelet surface receptors are critical for hemostasis, immune interactions, and coagulation, making them key therapeutic targets.

Purpose of the Study:

• To investigate molecular alterations in platelet surface receptor expression in ACS.
• To identify changes in specific platelet receptors and their regulatory microRNAs.
• To elucidate the molecular underpinnings of platelet dysfunction in ACS.

Main Methods:

• Analysis of mRNA and protein expression of key platelet receptors (P2Y12, GP1BB, ITGA2B, ITGB3).
• Quantification of P2Y12 and GP IIb/IIIa protein levels.
• Confocal and cytometric visualization to confirm P2Y12 upregulation.
• Evaluation of microRNA (miR-223-3p, miR-126-3p) expression potentially regulating P2Y12.

Main Results:

• Augmented mRNA expression of P2Y12, GP1BB, ITGA2B, and ITGB3 was observed in ACS patients.
• Increased protein concentrations of P2Y12 and GP IIb/IIIa were detected.
• Upregulation of P2Y12 at the protein level was confirmed via advanced imaging techniques.
• Expression levels of miR-223-3p and miR-126-3p were assessed in relation to P2Y12 regulation.

Conclusions:

• This study identifies specific molecular alterations in platelet surface receptors and associated microRNAs in ACS.
• Findings provide novel insights into the molecular mechanisms driving platelet hyperactivity in Acute Coronary Syndrome.
• Understanding these molecular changes may pave the way for new therapeutic strategies targeting platelet function in ACS.